Panton-Valentine leukocidin-positive Staphylococcus aureus: a position statement from the International Society of Chemotherapy

Int J Antimicrob Agents. 2018 Jan;51(1):16-25. doi: 10.1016/j.ijantimicag.2017.11.002. Epub 2017 Nov 22.
No abstract available

Keywords: CA-MRSA; Infection control; MSSA; PVL; Panton–Valentine leukocidin; Staphylococcus aureus.

Publication types

  • Editorial
  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Bacterial Toxins / metabolism*
  • Chlorhexidine / pharmacology
  • Community-Acquired Infections / drug therapy
  • Community-Acquired Infections / microbiology
  • Community-Acquired Infections / prevention & control
  • Exotoxins / metabolism*
  • Humans
  • Leukocidins / metabolism*
  • Methicillin-Resistant Staphylococcus aureus / drug effects
  • Mupirocin / pharmacology
  • Pets
  • Pneumonia, Bacterial / drug therapy
  • Pneumonia, Bacterial / microbiology
  • Prevalence
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / epidemiology
  • Staphylococcal Infections / etiology*
  • Staphylococcal Infections / prevention & control
  • Staphylococcal Skin Infections / drug therapy
  • Staphylococcal Skin Infections / microbiology
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / metabolism*
  • Staphylococcus aureus / pathogenicity
  • Zoonoses / microbiology

Substances

  • Anti-Bacterial Agents
  • Bacterial Toxins
  • Exotoxins
  • Leukocidins
  • Panton-Valentine leukocidin
  • Mupirocin
  • Chlorhexidine